Market Tracker

05/31 10:10am ET

Hemispherx Biopharma Inc (NYSE MKT LLC:HEB)

0.1202
Delayed Data
As of 9:51am ET
 -0.002 / -1.64%
Today’s Change
0.06
Today|||52-Week Range
0.24
+49.32%
Year-to-Date
No recent news for Hemispherx Biopharma Inc.

Today’s Trading

Previous close0.12
Today’s open0.12
Day’s range0.12 - 0.12
Volume60,328
Average volume (3 months)653,596
Market cap$30.3M
Dividend yield--
Data as of 9:51am ET, 05/31/2016

Growth & Valuation

Earnings growth (last year)+33.33%
Earnings growth (this year)--
Earnings growth (next 5 years)+35.00%
Revenue growth (last year)-32.49%
P/E ratioNM
Price/Sales142.93
Price/Book1.48

Competitors

 Today’s
change
Today’s
% change
ABIOARCA Biopharma Inc+0.06+1.79%
CTRVContraVir Pharmaceut...+0.01+1.09%
EYEGEyeGate Pharmaceutic...+0.03+0.82%
OGXIOncoGenex Pharmaceut...+0.03+3.09%
Data as of 10:08am ET, 05/31/2016

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$133.0K
Annual profit (last year)-$15.2M
Net profit margin-11,451.13%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Secretary &
General Counsel
Thomas Kenwood Equels
Senior Vice President-
Operations
Wayne S. Springate
Corporate headquarters
Philadelphia, Pennsylvania

Forecasts